The future of healthcare is undeniably heading toward cell therapies, as they offer hope for diseases where, to date, we have not been able to provide treatments or cures.
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
